KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Gross Profit: 2009-2025

Historic Gross Profit for Arbutus Biopharma (ABUS) over the last 16 years, with Sep 2025 value amounting to $529,000.

  • Arbutus Biopharma's Gross Profit fell 60.49% to $529,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 116.64%. This contributed to the annual value of $6.2 million for FY2024, which is 65.98% down from last year.
  • As of Q3 2025, Arbutus Biopharma's Gross Profit stood at $529,000, which was down 95.07% from $10.7 million recorded in Q2 2025.
  • In the past 5 years, Arbutus Biopharma's Gross Profit registered a high of $14.2 million during Q2 2022, and its lowest value of $529,000 during Q3 2025.
  • In the last 3 years, Arbutus Biopharma's Gross Profit had a median value of $1.8 million in 2025 and averaged $3.4 million.
  • Per our database at Business Quant, Arbutus Biopharma's Gross Profit crashed by 77.09% in 2024 and then skyrocketed by 522.19% in 2025.
  • Arbutus Biopharma's Gross Profit (Quarterly) stood at $3.2 million in 2021, then skyrocketed by 94.79% to $6.2 million in 2022, then plummeted by 65.65% to $2.1 million in 2023, then dropped by 26.62% to $1.6 million in 2024, then slumped by 60.49% to $529,000 in 2025.
  • Its last three reported values are $529,000 in Q3 2025, $10.7 million for Q2 2025, and $1.8 million during Q1 2025.